the aid library

LIST OPTIONS

Filter

7537

Dementia - Toolkit for community workers in low- and middle-income countries

Mercado, S. World Health Organization (Pacific Region) (2018) C_WHO

Guide for community-based management and care of people with dementia Version 1.0 Mental Health and Substance Abuse Division of NCD and Health through the Life-Course World Health Organization Regional Office for the Western Pacific

Download (277)

View PDF (329)

Preventing HIV and other sexually transmitted infections among women and girls using contraceptive services in contexts with high HIV

UNAIDS; WHO; hrp (2020) C_WHO

This programmatic brief explores how to expand HIV and STI prevention and contraceptive method options in contraceptive services and, thus, to reduce HIV and STI incidence among adolescent girls and women. It focuses on settings with extremely high HIV prevalence and incidence. This brief complement... more

External Link

Preventable Epilepsy: Taenia Solium Infection Burdens Economies, Societies and Individuals

World Health Organization WHO (2016) C_WHO

Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ... more

External Link

The social context of schistosomiasis and its control: an introduction and annotated bibliography

Bruun, B.; Aagaard-Hansen, J.; Watts, S. World Health Organization WHO; Institutional Repository for Information Sharing iris (2008) C_WHO

Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must b... more

Download (297)

View PDF (301)

Training Needs Assessment of Health Workers on Health Care Waste Management in Kenya

UNDP (2018) CC

This report contains the results of an in-depth Training Needs Assessment (TNA) of Health Workers in the 4 project counties of the republic of Kenya – Nakuru, Kisumu, Nairobi and Bungoma. The assessment, facilitated by the UPOPs Project in close collaboration with the Ministry of Health and Minist... more

Download (405)

View PDF (290)

WHO recommendations on drug treatment for non-severe hypertension in pregnancy
recommended

World Health Organization WHO (2020) C_WHO

The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi... more

Download (455)

View PDF (388)

Scale-up of severe wasting management within the health system: A stakeholder perspective on current progress

Emergency Nutrition Network ENN (2021) CC

A wide range of potential enablers and barriers were identified for influencing progress for the scale-up of severe wasting services within national health systems. Findings were categorised according to the six pillars of WHO’s health system strengthening framework.

Download (205)

View PDF (217)

Implementation of the HIV Prevention 2020 Road Map. Fourth Progress Report Nov. 2020

UNAIDS (2020) C_WHO

This fourth progress report November 2020 of the Global HIV Prevention Coalition reviews the progress in the 28 focus countries and complements the three previous progress reports. This report describes key developments in 2019–2020, identifies challenges and opportunities (including those associa... more

Download (164)

View PDF (190)

Creating HIV prevention cascades — Operational guidance on a tool for monitoring programmes

UNAIDS (2021) C_WHO

This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sites.

Download (2011)

View PDF (542)

Guidelines on Chemical Management in Health Care Facilities

Ministry of Health Malaysia (2010) C1

Specific Objectives • To increase the knowledge and awareness of personnel on chemical management. • To educate the personnel on the potential adverse health effects of chemical exposure. • To educate the personnel on the existing laws pertaining to handling of hazardous chemicals. • To... more

Download (258)

View PDF (215)

HIV Molecular diagnostics Toolkit to improve access to viral load testing and infant diagnosis

WHO World Health Organization (2019) C_WHO

Toolkit HIV Treatment and Care

Download (489)

View PDF (165)

Biomedical equipment for COVID-19 case management - inventory tool: Interim guidance

World Health Organization WHO (2020) C_WHO

Countries can use this tool to collect in-depth facility inventories of biomedical equipment re-allocation, procurement and planning for COVID-19 case management. The survey assesses quantified availability and the causes for non-functioning of different sources of oxygen delivery and supply systems... more

Download (265)

View PDF (322)

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level
recommended

World Health Organization WHO (2020) C_WHO

This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ... more

External Link

Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen

Ferreyra C., D. O’Brien, B. Alonso Conflict and Health (2018) C2

Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen.

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (721)

View PDF (1593)

HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV

World Health Organization (2013)

These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents

Download (457)

View PDF (401)

Religious and Spiritual Factors in Depression: Review and Integration of the Research

Bonelli, R.; R. E. Dew, H.G. Koenig, et al. (2012) CC

Depression Research and Treatment Volume 2012, Article ID 962860, 8 pages doi:10.1155/2012/962860

Download (1016)

View PDF (2031)

Essential for Excellence. Research, Monitoring and Evaluation Strategic Communication for Behaviour and Social Change

UNICEF (2008)

with special reference to prevention and control of avian influenza

External Link

Guidance on Law and Public Health Emergency Preparedness and Response

International Federation of Red Cross and Red Crescent Societies IFRC (2023) CC

The domestic regulation of public health emergencies (PHEs) is inextricably linked to the regulation of other types of disaster. PHEs are usually governed at least partly by general disaster and emergency laws. Moreover, there is significant overlap in the legal mechanisms used to respond to PHEs an... more

External Link

Professionalizing Health Logistics in Burkina Faso: Challenges, Implementation and Sustainability

Silve B., A. Ouedraogo Public Health Research (2013) C2

The management of information and logistics is an essential component of health product systems. In a context of limited financial resources and morbidity and mortality sustained by persistent diseases, it is necessary to strengthen health systems through competent resources, especially human resour... more

WHO recommendations on drug treatment for non-severe hypertension in pregnancy recommended

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level recommended

WHO recommendations on drug treatment for non-severe hypertension in pregnancy
recommended

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level
recommended